2016 Fellowship - Family Planning, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI
2015 MSc - Masters of Health and Health Care Research, University of Michigan, Ann Arbor, MI
2014 Residency - Ob/Gyn, University of Vermont College of Medicine/Fletcher Allen Health Care, Burlington, VT
2010 M.D. - University of Minnesota Medical School, Minneapolis, MN
2005 B.S. - Biochemistry, University of Mary Washington, Fredericksburg, VA
Dr. MacAfee's primary area of focus is family planning and she is interested in improving access to both contraception and abortion using health services research. More specifically, her ongoing research seeks to better understand barriers to reproductive health care for women with substance use disorders. Dr. MacAfee is also active and interested in undergraduate and graduate medical education particularly around family planning.
2019 Leonard Tow Humanism in Medicine Faculty Award, Larner College of Medicine, University of Vermont
2018 Member, Teaching Academy, Larner College of Medicine, University of Vermont
2018 Best Poster Award for Sexual and Reproductive Health Section, American Public Health Association Annual Conference
2018 Teacher and Student Advocate Award, Clerkship Class of 2020, Larner College of Medicine, University of Vermont
2018 Teacher and Student Advocate Award, Clerkship Class of 2019, Larner College of Medicine, University of Vermont
2017 Teacher and Student Advocate Award, Clerkship Class of 2018, Larner College of Medicine, University of Vermont
2017 Ob/Gyn Clerkship Medical Student Teaching Award, Rotation 6, Larner College of Medicine, University of Vermont
2015 Fellow of the Year Teaching Award, Department of Obstetrics and Gynecology, University of Michigan Medical School
2014 Arnold P. Gold Foundation Humanism and Excellence in Teaching Award, University of Vermont College of Medicine
2014 Ob/Gyn Clerkship Medical Student Teaching Award, Rotation 7, University of Vermont College of Medicine
2013 Ryan Resident Scholarship Recipient, North American Forum in Family Planning
2013 Ob/Gyn Clerkship Medical Student Teaching Award, Rotations 3 and 5, University of Vermont College of Medicine
2012 District I Representative, American Congress of Obstetricians and Gynecologists, Annual Clinical Meeting Reporter Program
2012 Best Resident Teacher, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Vermont College of Medicine
2009 Neil L. and Sarah Gault International Study Award, University of Minnesota Medical School
MacAfee L, Castle J, Theiler R. Association Between the New Hampshire Parental Notification Law and Minors Undergoing Abortions in Northern New England. Obstet Gynecol 2015 125(1) 170-174
Short V, Hand D, MacAfee L, Abatemarco D, Terplan M. Trends and disparities in receipt of pharmacotherapy among pregnant women in publically funded treatment programs for opioid use disorder in the United States. J Subst Abuse Treat 2018 Jun; 89:67-74. doi: 10.1016/j.jsat.2018.04.003
MacAfee LK, Dalton V, Terplan M. Pregnancy Intention, Risk Perception, and Contraceptive Use in Pregnant Women Who Use Drugs. J Addict Med. 2018 Nov 2. doi: 10.1097/ADM.0000000000000471
Hurissa T, Bell J, Wondafresh M, Surur F, MacAfee L, Dalton V, Kahn C, Yanik M. Outcomes of Second Trimester Surgical Abortion: The Experience ofTertiary Health Facility in Ethiopia. Ethiopian J Repro Health. 2019 Jan:11:
Collier KW, MacAfee LK, Kenny BM, Meyer MC. Does co-location of medication assisted treatment and prenatal care for women with opioid use disorder increase pregnancy planning, length of interpregnancy interval, and postpartum contraceptive uptake? J Subst Abuse Treat. 2019 Mar; 98:73-77. doi: 10.1016/j.jsat.2018.12.001
MacAfee LK, Harfmann RF, Cannon LM, Minadeo L, Kolenic G, Kusunoki Y, Dalton VK. Substance Use Treatment Patient and Provider Perspectives on Accessing Sexual and Reproductive Health Services: Barriers, Facilitators, and the Need for Integration of Care. Subst Use Misuse. 2019 Aug 27:1-13. doi: 10.1080/10826084.2019.1656255.
MacAfee LK, Harfmann RF, Cannon LM, Kolenic G, Kusunoki Y, Terplan M, Dalton VK. Sexual and Reproductive Health Characteristics of Women in Substance Use Treatment in Michigan. Obstet Gynecol. 2020 Feb;135(2):361-369. doi: 10.1097/AOG.0000000000003666.
Rey CN, Badger GJ, Melbostad HS, Wachtel D, Sigmon SC, MacAfee LK, Dougherty AK, Heil SH. Perceptions of Long-Acting Reversible Contraception Among Women Receiving Medication for Opioid Use Disorder in Vermont. Contraception. 2020 May; 101(5):333-337. doi: 10.1016/j.contraception.2020.01.010
Melbostad HS, Badger GJ, Rey CN, MacAfee LK, Dougherty AK, Sigmon SC, Heil SH. Contraceptive knowledge among females and males receiving opioid agonist treatment compared to those seeking primary care services. Subst Use Misuse 2020;55(14):2403-2408. doi: 10.1080/10826084.2020.1823418. PMID: 33019893.
Tolu LB, Tufa TH, Abad F, Kahn C, MacAfee L, Prager S, Bell JD. Intra-cardiac lidocaine administration to induce fetal demise before late second-trimester abortion: retrospective review. Int J Gynaecol Obstet 2021 Apr; 153(1)125-129 doi: 10.1002/ijgo.13419. PMID: 33043458.
Heil S, Melbostad H, Matusiewicz A, Rey C, Badger G, Shepard D, Sigmon S, MacAfee L, Higgins S. Efficacy and Cost-Benefit Analysis of Contraceptive Services With and Without Incentives Among Women with Opioid Use Disorder and at High Risk for Unintended Pregnancy: A Randomized Controlled Trial. JAMA Psychiatry 2021, Jul 14 doi: 10.1001/jamapsychiatry.2021.1715. PMID 34259798
Melbostad, H.S., Wachtel, D.S., Lipke, K.A., Badger, G.J., Matusiewicz, A.K., Rey, C.N., MacAfee, L.K., Dougherty, A.K., & Heil, S.H. Preliminary side effect profile, safety, and tolerability of hormonal contraception among women receiving opioid-agonist therapy. Contraception. 2022 Jun;110:16-20. doi: 10.1016/j.contraception.2022.02.013. Epub 2022 Mar 11.
McCartin M, Cannon L, Harfmann R, Dalton V, MacAfee L, and Kusunoki Y. Stigma and reproductive health service access among women in treatment for substance use disorder. Womens Health Issues. 2022 Jul 9:S1049-3867(22)00056-1. doi: 10.1016/j.whi.2022.06.003
See PubMed listing here.